Spots Global Cancer Trial Database for Registry Study - Whipple at the Splenic Artery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Registry Study - Whipple at the Splenic Artery

Official Title: Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study

Study ID: NCT01155882

Conditions

Pancreas Cancer

Interventions

Whipple at the Splenic Artery (WATSA)

Study Description

Brief Summary: The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).

Detailed Description: Primary The primary objective of this registry study is to collect clinical data from patients who undergo the WATSA procedure. Specific hypotheses to be tested are * To determine how effective Whipple at the Splenic Artery (WATSA) is at resecting tumors with negative microscopic margins (R0) at the resection line on the pancreas and at the tangential posterior, uncinate, and venous margins. * To determine if WATSA can be performed within the usual range of morbidity and mortality (30 day postoperative mortality) for a standard a Whipple procedure. Secondary The secondary objectives of this registry study are to * To determine the survival/recurrence rates at 2 years. * To determine the effect of occlusion of the splenic vein at the confluence.